![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 53, 38027-38031, December 31, 1999
andFrom the Department of Anatomy and Cell Biology, McGill University, Montréal, Québec H3A 2B2, Canada and the Bloomfield Centre for Research in Aging, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, Montréal, Québec H3T 1E2, Canada
| |
ABSTRACT |
|---|
|
|
|---|
Telomerase is a ribonucleoprotein enzyme complex
that adds DNA repeats at the ends of chromosomes. In an effort to
establish an in vivo heterologous expression system for
active human telomerase, we expressed human
telomerase reverse transcriptase
(hTERT) in Saccharomyces cerevisiae and affinity-purified
the protein as a fusion with glutathione S-transferase
(GST). Addition of the GST moiety to the N terminus of hTERT did not
interfere with telomerase activity when GST-hTERT was expressed in
rabbit reticulocyte lysate (RRL) in the presence of the human
telomerase RNA (hTR). Active human telomerase was immunoprecipitated
from yeast lysates that co-expressed GST-hTERT and hTR. In addition,
telomerase activity could be reconstituted in vitro by the
addition of hTR to GST-hTERT that was immunoprecipitated from either
RRL or S. cerevisiae lysates. The expression and
reconstitution of human telomerase activity in yeast will provide
powerful biochemical and genetic tools to study the various components
required for the assembly and function of this enzyme.
Eukaryotic cells possess linear chromosomes that are predicted to
lose terminal sequences after every DNA replication event (1, 2). To
circumvent this end replication problem, most eukaryotic cells possess
a ribonucleoprotein (RNP)1
enzyme, telomerase, which uses its RNA template to synthesize DNA
repeats at the ends of chromosomes (3-5). The protein and RNA
components of this enzyme complex have been identified in several
organisms from yeast to humans (3, 6). In humans, the catalytic subunit
of telomerase (hTERT, for human telomerase reverse transcriptase) is a 127-kDa protein with
distinctive motifs common to reverse transcriptases (RT) as well as a
telomerase-specific (T) motif (7-10).
The first in vitro reconstitution system used to study human
telomerase consisted of adding recombinantly synthesized human telomerase RNA (hTR) to partially purified, micrococcal
nuclease-treated 293 cell extracts (11). More recently, human and
Tetrahymena thermophila telomerase reconstitution has been
accomplished by the in vitro transcription and translation
of the protein catalytic component (hTERT and p133, respectively) in
the presence of telomerase RNA in rabbit reticulocyte lysates (RRL)
(12-14). Studies using RRL-reconstituted telomerase suggest that hTERT
and hTR are the only two components necessary to reconstitute human
telomerase activity in vitro. Interaction of the
telomerase-associated protein (TP1) with telomerase, which is observed
in mouse cell extracts, was not seen in RRL (13, 15). However, several
lines of evidence suggest that proteins in the RRL are necessary for
the assembly of a functional telomerase enzyme. Using the yeast
two-hybrid system, Holt and co-workers (16) identified a chaperone
protein, p23, that interacts with hTERT and that could be associated
with a complex called "the foldosome," important for
ribonucleoprotein assembly. In addition, a recent study on the role of
the T. thermophila telomerase RNA in telomerase function
suggests that proteins other than the catalytic subunit are necessary
for the functional assembly of this RNP in rabbit reticulocyte lysates
(17).
Telomerase is active in most transformed and tumor cell lines, whereas
the majority of normal diploid cells demonstrate no detectable
telomerase activity (1, 18, 19). Consequently, the telomerase enzyme
has become an attractive target for chemotherapy. A better
understanding of the biogenesis and structure of this RNP complex will
therefore be necessary to evaluate the role of telomerase in cellular
immortalization and cancer. Reconstitution of the telomerase RNP by
overexpression of its components in heterologous organisms will be
crucial to the study of the molecular mechanisms of this enzyme. In
this study, we investigated whether human telomerase activity could be
reconstituted by expressing hTERT and hTR in Saccharomyces
cerevisiae. We describe the expression and glutathione-Sepharose affinity purification of the human telomerase catalytic subunit as a
fusion to glutathione S-transferase (GST) in yeast. In
addition, we demonstrate that S. cerevisiae is capable of
reconstituting a functional human telomerase enzyme when GST-hTERT and
hTR are co-expressed.
Yeast Strain--
Yeast strain cIABYS86 (MAT Construction of Plasmids--
Clone 712562, containing bases
1624-3399 of the hTERT coding sequence and 3' downstream sequences,
was obtained from the IMAGE (Integrated Molecular Analysis of Genomes
and their Expression) Consortium through Genome System Inc. and was
used for construction of an hTERT mutation using the Quick Change
site-directed mutagenesis kit from Stratagene (21). The
oligonucleotides 5'-CTCCTGCGTTTGGTTAACGATTTCTTGTTG-'3 and
5'-CAACAAGAAATCGTTAACCAAACGCAGGAG-'3 were used to generate the D868N
mutation and to create a HincII restriction site. This new
construct (phTRTDNC) was sequenced using an Applied Biosystems automatic sequencer to confirm the presence of the mutation.
To generate the hTERT expression plasmids, the htert gene
from pGRN121 (7) was amplified by PCR with the 5' primer
5'-TGCTCTAGACCCGCGCGCTCCCCGC-'3 and the 3' primer
5'-CCCAAGCTTGGCGGGTGGCCATCAGTC-'3 containing XbaI and
HindIII sites, respectively, as well as with the 5' primer 5'-CCGGAATTCTATGCCGCGCGCTCCCC-'3 and the 3' primer
5'-GAATGCGGCGCGTCAGTCCAGGATGGTCTTG-'3 containing EcoRI
and NotI sites, respectively. The
XbaI-HindIII- and
EcoRI-NotI-digested PCR fragments were then
cloned in pEGKT (22) digested with XbaI-HindIII
and in pET-28b (Novagen) digested with
EcoRI-NotI, respectively. To generate the hTERT
D868N yeast expression construct, a 2.5-kilobase
MluI-HindIII fragment of pEGKT-hTERT was replaced
with a MluI-HindIII fragment from a derivative of
phTRTDNC containing the D868N mutation. To generate the
pET-28a·GST-hTERT construct, the pEGKT-hTERT plasmid was linearized
by digestion with HindIII. This linearized construct was
subjected to partial digestion by the SacI restriction
enzyme using a standard method (23). This resulted in a 4150-bp
GST-hTERT DNA fragment, which was gel-purified and cloned into the
SacI-HindIII sites of pET-28a (Novagen). To
construct the hTR yeast expression vector, the hTR gene was
amplified by PCR from pGRN33 (24) using the 5' primer 5'-CGCGGATCCCGGCAGCGCACCGGGTTGCGG-'3 and the 3' primer
5'-CGCGGATCCGCATGTGTGAGCCGAGTCCTGGGT-'3, both containing
BamHI restriction sites. The BamHI-digested PCR fragment was cloned into the BamHI site of the p413-GAL1
vector (25).
Protein Expression and Affinity Purification--
Yeast
containing the different constructs were grown in selective medium
containing 2% raffinose to A600 nm 0.6-0.8. To induce transcription from the GAL1 promoter, galactose
was added to a final concentration of 4%, and growth continued for 12-16 h. Cells were harvested, washed with sterile water, and resuspended in either radioimmune precipitation buffer (RIPA) or TMG
buffer (26). Because of the inefficiency of the yeast protein
extraction, 25 ml of a yeast culture was lysed by vortexing with glass
beads for 6 pulses of 30 s with at least a 1-min interval (4 °C) between each pulse. After removal of the glass beads and cell
debris by two centrifugations (10,000 × g) at 4 °C,
the specific proteins in the lysates were affinity-purified by the
addition of glutathione-Sepharose (Amersham Pharmacia Biotech) for
2 h at 4 °C, washed four times with lysis buffer (supplemented
with NaCl to a final concentration of 0.5 M), and subjected
to SDS-PAGE for either Coomassie Blue (Bio-Rad) staining or
nitrocellulose transfer.
In Vitro Transcription and Translation--
pET-28b·hTERT and
pET-28a·GST-hTERT plasmids were included in coupled
transcription/translation (Promega) reactions (10-15 µl) at a final
concentration of 25 ng/µl, with or without 10 ng/µl of gel-purified
hTR telomerase RNA. Gel-purified human and T. thermophila
telomerase RNA were generated as described previously (11, 27).
Immunoprecipitations--
Immunoprecipitations were performed
using yeast protein lysates (in TMG buffer) or 2-3 µl of
reticulocyte lysate previously diluted into 500 µl of Buffer A (11).
After a 1-h incubation at 4 °C with preimmune serum, lysates were
subjected to immunoprecipitation with specific antibodies (anti-GST
from Amersham Pharmacia Biotech; anti-T7 from Novagen; anti-MYC from
Invitrogen) for 1 h at 4 °C. This was followed by incubation
with pre-washed and lysis buffer-pre-equilibrated protein A-Sepharose
(Amersham Pharmacia Biotech) for an additional 2 h.
Antibody-coated beads were then washed four times with the respective
lysis buffer and subjected to SDS-PAGE/Western blot analysis, TRAP
assay, and RT-PCR.
Telomerase Activity Assays--
Telomerase activity was assayed
by a two-tube telomerase assay (modified TRAP) as described previously
(11), with minor modifications; PCR reactions were performed for 25 cycles of 94 °C for 30 s, 60 °C for 30 s, and 72 °C
for 1 min 30 s, using Taq polymerase from MBI
Fermentas. ACX, TSNT, and NT primers (28) were used at a final
concentration of 0.4 pmol/µl, 2 × 10 Expression and Activity of a GST-hTERT Fusion in Rabbit
Reticulocyte Lysates--
Since the cloning of the gene encoding the
catalytic subunit of the human telomerase enzyme, reconstitution of
enzymatic activity has been achieved by expressing hTERT in the
presence of hTR in rabbit reticulocyte lysates (12, 13). To extend the
study of human telomerase, we expressed a GST-tagged hTERT in yeast (Fig. 2). To first determine whether the GST moiety fused to the N
terminus of hTERT interfered with telomerase function, the entire GST-hTERT coding sequence from pEGKT-hTERT was cloned into a T7 expression vector (see "Materials and Methods"). This GST-hTERT construct was transcribed and translated in a RRL in the presence of
hTR and was immunoprecipitated using a goat anti-GST antibody (Fig.
1B, lane 15). The
immunoprecipitate was then assayed for telomerase activity using a
modified TRAP assay (see "Materials and Methods"). The
GST-hTERT·hTR complex was active in the telomerase assay (Fig.
1A, lane 15), whereas no telomerase activity was
detected when a T7-tagged hTERT·hTR complex was subjected to
immunoprecipitation using the same anti-GST antibody (Fig.
1A, lane 14). As expected, immunoprecipitation of
hTERT or GST-hTERT proteins synthesized in the absence of hTR did not
reconstitute telomerase activity (Fig. 1A, lanes
7, 8, and 13), although these proteins were
expressed (Fig. 1B). Immunoprecipitates of hTERT·hTR or
GST-hTERT·hTR complexes were also prepared with a monoclonal antibody
recognizing a small tag (T7 tag) fused to the N terminus of both
proteins (Fig. 1B, lanes 9 and 10).
Both T7-tagged immunoprecipitated complexes demonstrated telomerase
activity (Fig. 1A, lanes 9 and 10).
Immunoprecipitates prepared with a control anti-MYC antibody did not
possess detectable telomerase activity (Fig. 1A, lanes
1-5). The results shown in Fig. 1 indicate that
addition of the 25-kDa GST protein to the N terminus of the human
telomerase catalytic subunit does not prevent the functional
reconstitution of telomerase activity by hTERT in RRL.
Expression and Affinity Purification of the Human Telomerase
Catalytic Component from S. cerevisiae--
The GST-hTERT fusion
protein was expressed in S. cerevisiae under the control of
the galactose-inducible GAL1 promoter. Lysates were prepared
from yeast grown in glucose (repressed) or galactose (induced) and
subjected to glutathione-Sepharose batch affinity chromatography. The
GST-hTERT fusion produced by yeast grown in galactose (Fig.
2A, lane 4) was
affinity-purified with glutathione-Sepharose and migrated with a
molecular mass of approximately 150 kDa (Fig. 2A, lane
1), consistent with hTERT and GST components of 125 and 25 kDa
(lane 6), respectively. This fusion protein was not detected in extracts from uninduced yeast grown in glucose (Fig. 2A,
lanes 2 and 5). The 150-kDa fusion was confirmed
to be GST-hTERT in a Western blot (Fig. 2B, lanes
3 and 6) probed with an affinity-purified anti-hTERT
antibody (9). No protein was detected with the anti-hTERT antibody in:
(i) glutathione-Sepharose-purified proteins or crude lysate isolated
from uninduced yeast (lanes 4 and 7,
respectively); or (ii) lysates from yeast expressing a GST control
(lanes 5 and 8). T7-tagged hTERT synthesized in
RRL (Fig. 2B, lane 1) was used as a positive
control. Species smaller than the full-length hTERT (which may be
nonspecific cleavage products, products from initiation at downstream
AUG, or premature translation termination) are routinely detected from
RRL expressing hTERT with this antibody (13).
Reconstitution of Human Telomerase Activity by Co-expression of
hTERT and hTR in S. cerevisiae--
As the GST-hTERT fusion expressed
in RRL was functional and reconstituted human telomerase activity (Fig.
1), we examined whether telomerase activity could be reconstituted in
S. cerevisiae by co-expressing the catalytic and the RNA
components. The gene encoding the hTR RNA was also cloned under the
control of a GAL1 promoter. This construct was transformed
into yeast cells expressing GST, wild-type GST-hTERT, or GST-hTERT with
a point mutation at amino acid 868 that changes a conserved
Asp868 residue to an asparagine in motif C of hTERT.
Following selection of the double transformants, we examined the
expression of hTR in yeast that were grown in medium containing
galactose. Reverse transcription and polymerase chain reaction (RT-PCR)
on total yeast RNA using hTR-specific primers confirmed the presence of hTR in yeast transformed with the hTR-expressing construct; this specific RNA was not detected in control yeast transformed with the
vector alone (data not shown).
Once an inducible system for co-expression of hTERT and hTR in S. cerevisiae was established, cell lysates were prepared from yeast
grown in selective media containing galactose or glucose. Yeast cell
lysates were subjected to immunoprecipitation using an anti-GST serum,
and the immunoprecipitates were analyzed for telomerase activity (Fig.
3A). Immunoprecipitates from
two independent yeast clones co-expressing the wild-type GST-hTERT and
hTR were positive for telomerase activity as analyzed by the TRAP assay (Fig. 3A, lanes 3 and 4). To ensure
that the activity was due to hTERT rather than a co-immunoprecipitating
protein, the D868N hTERT mutant was also immunoprecipitated and was
shown to lack telomerase activity (Fig. 3A, lane
6). The lack of telomerase activity observed for this active site
point mutant suggests that the activity observed in lanes 3 and 4 is attributable to hTERT and also confirms that the
integrity of motif C is essential for activity (12, 13, 29, 30). RT-PCR
analysis of the immunoprecipitates revealed that hTR was specifically
associated with the reconstituted telomerase (Fig. 3C,
lanes 3 and 4), as well as with the D868N GST-hTERT point mutant (lane 6). RT-PCR analysis of
immunoprecipitates from control yeast that expressed GST alone did not
detect hTR (Fig. 3C, lane 7).
Reconstitution of telomerase activity as well as expression of the
protein and RNA components of human telomerase were only detected from
yeast grown in galactose-containing medium. Growth under repressing
conditions (glucose) did not induce the expression of hTERT (Fig.
3B, lane 5) or hTR (data not shown),
demonstrating the specificity of the expression system. Human
telomerase activity could not be detected using immunoprecipitates from
yeast transformed with control vectors (Fig. 3A, lanes
1 and 7), confirming that both hTERT and hTR components
were required to reconstitute human telomerase activity. The results
shown in Fig. 3 demonstrate that co-expression of hTERT and hTR in
S. cerevisiae specifically reconstituted human telomerase activity.
S. cerevisiae Lysate Does Not Stimulate Assembly of the
GST-hTERT·hTR Complex in Vitro--
Recent reports suggest that
in vitro reconstitution of human and T. thermophila telomerase RNPs requires proteins present in rabbit
reticulocyte lysates (16, 17). Similarly, we asked whether the
reconstitution of telomerase activity by the addition of hTR to
immunoprecipitated hTERT may be dependent on proteins present in
S. cerevisiae lysate. We used anti-GST serum to
immunoprecipitate RRL-expressed GST-hTERT synthesized in the absence of
the human telomerase RNA, as well as S. cerevisiae-expressed
wild-type and D868N mutant GST-hTERT, which were expressed in the
absence of the hTR-expressing construct. Following extensive washing,
the immunoprecipitated proteins were incubated with either human or T. thermophila telomerase RNA in the presence or absence of
a fresh yeast protein extract. After a 45-min incubation at 30 °C, reconstituted reactions were assayed for telomerase activity. The
addition of fresh yeast protein extract was neither required for nor
stimulated the telomerase activity reconstituted by the assembly of hTR
with immunoprecipitated RRL- or S. cerevisiae-expressed GST-hTERT (Fig. 4, lane 1 versus lane 2 and lane 7 versus lane 8, respectively). Addition of
T. thermophila telomerase RNA did not reconstitute human
telomerase activity (lanes 3 and 9), highlighting the specificity of the reconstitution reaction for human telomerase RNA. Incubation of human telomerase RNA with the S. cerevisiae-expressed and immunoprecipitated GST-hTERT D868N mutant
did not reconstitute activity (Fig. 4, lanes 4 and
5), confirming the requirement for a catalytically active
hTERT component. In addition to using immunoprecipitated GST-tagged
hTERT in reconstitution reactions, we also expressed a T7-tagged hTERT
in RRL, immunoprecipitated the protein with a monoclonal anti-T7
antibody, and functionally reconstituted telomerase activity by adding
only hTR (data not shown). The results presented in Fig. 4 suggest that
the in vitro assembly of a functional hTERT·hTR telomerase
RNP using immunoprecipitated hTERT does not require factors from the
yeast protein lysate.
We have expressed and affinity-purified the catalytic subunit of human
telomerase as a GST fusion in the yeast S. cerevisiae. To
our knowledge, this is the first report that describes the heterologous
expression of a catalytically active, full-length, recombinant hTERT in
a system other than rabbit reticulocyte lysate. We demonstrated that
the GST-hTERT fusion functions to reconstitute human telomerase
activity in RRL when synthesized in the presence of recombinant human
telomerase RNA. We also showed that co-expression of GST-hTERT and hTR
in S. cerevisiae produced a telomerase enzyme complex that
was catalytically active in vitro.
Quantification of the relative telomerase activity reconstituted by the
addition of in vitro synthesized hTR to affinity-purified GST-hTERT generated from yeast or RRL indicate that comparable amounts
(as determined by silver staining) of GST-hTERT immunoprecipitated from
yeast or RRL yield similar levels of telomerase activity (Fig. 4 and
data not shown). However, the amount of active hTERT that can be
generated in yeast is limited only by the amount of yeast cultured and
the efficiency of the protein extraction, making the yeast system a
more abundant and practical source of active human telomerase than RRL.
Preliminary attempts to reconstitute human telomerase activity using
the soluble recombinant GST-hTERT fusion expressed from yeast and
in vitro synthesized hTR were unsuccessful (data not shown).
We found that the GST-hTERT·hTR complex synthesized in RRL and
precipitated with glutathione-Sepharose had significantly less
telomerase activity than the same complex precipitated with an anti-GST
antibody (data not shown; Fig. 1A, lane 15),
suggesting that the active conformation of the GST-hTERT fusion may be
altered upon binding to glutathione.
Recent in vitro studies indicate that the assembly of a
functional telomerase RNP enzyme requires specific protein components (16, 17). Two chaperone proteins, p23 and Hsp90, were suggested to be
important in the assembly of the human telomerase enzyme (16). The
ability to reconstitute a functional human telomerase RNP in the yeast
S. cerevisiae (Fig. 3) suggests that the cellular machinery
required for the folding and/or assembly of the human telomerase
catalytic subunit with its specific hTR may have been conserved through
evolution. However, reconstitution of telomerase activity in the
absence of yeast protein extracts using recombinantly synthesized hTR
and immunoprecipitated GST-hTERT, expressed from either RRL or S. cerevisiae (Fig. 4), suggests that yeast proteins may not be
essential for human telomerase RNP assembly and activity in
vitro. It is possible that proteins important for the assembly of
the telomerase RNP in vivo were co-immunoprecipitated with the GST-hTERT protein. It is also conceivable that nonphysiological in vitro levels of both hTERT and hTR can overcome an
in vivo requirement for factors that assemble the human
telomerase RNP. In vitro reconstitution of T. thermophila telomerase using immunoprecipitated p133 (catalytic
subunit of T. thermophila) expressed in RRL and Tetrahymena telomerase RNA is dependent on proteins from the
rabbit reticulocyte lysate, suggesting that human and T. thermophila telomerase may require different factors for RNP
assembly (17).
We have shown that active human telomerase can be extracted from yeast
co-expressing the hTERT and hTR components. Others have changed the
endogenous yeast telomerase RNA template to a human telomerase RNA
template to dictate the synthesis of TTAGGG repeats at yeast telomeres
without growth impairment (31). Whether the functional replacement of
yeast telomerase by human telomerase is possible in vivo is
presently under investigation. The in vivo expression of a
catalytically active recombinant hTERT in S. cerevisiae will
be useful for future genetic and biochemical studies.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
,
leu2, Ura3-52, his3, pra1,
prb2, prc1, cps) was used as a host
strain for hTERT protein expression and also as a source of yeast cell
lysate (20).
25 mol/µl, and
40 fmol/µl, respectively. Amplification of TSNT by TS and NT primers
generated a 36-bp PCR internal control (IC). The positive control used
in TRAP assays consisted of partially purified 293 cell extracts
prepared as described previously (11).
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

View larger version (68K):
[in a new window]
Fig. 1.
Telomerase activity of the GST-hTERT fusion
in rabbit reticulocyte lysates. A,
[35S]methionine-labeled hTERT and GST-hTERT were
synthesized in a rabbit reticulocyte lysate in the presence or absence
of the hTR. As a control, RRL synthesis was performed with hTR RNA only
(lanes 1, 6, and 11). Aliquots from
each reaction were diluted with buffer (see "Materials and
Methods") and immunoprecipitated using anti-MYC (lanes
1-5), anti-T7 (lanes 6-10), or
anti-GST (lanes 11-15) antibodies. After
extensive washing, one-tenth of the immunoprecipitate (IP)
was assayed for telomerase activity (A), and the remnant of
the beads were subjected to SDS-PAGE and autoradiography
(B). 293, 0.1 µg of partially purified 293 cell
extract; IC, internal PCR control for the TRAP assay.

View larger version (45K):
[in a new window]
Fig. 2.
Expression and affinity purification of the
human telomerase catalytic subunit from S. cerevisiae. A, GST-hTERT was expressed and
purified from yeast by affinity chromatography of crude extracts using
glutathione-Sepharose. Lane M, molecular mass markers (in
kilodaltons); lanes 5 and 10, uninduced soluble
fractions; lanes 4 and 9, induced soluble
fractions; lanes 3 and 8, unbound fractions from
glutathione-Sepharose; lanes 2 and 7, bound
fractions from uninduced yeast lysate; lanes 1 and
6, bound fractions from galactose-induced yeast lysate.
B, glutathione-Sepharose-purified and crude lysate fractions
from galactose-induced GST (lanes 5 and 8,
respectively), uninduced (lanes 4 and 7,
respectively), and galactose-induced (lanes 3 and
6, respectively) GST-hTERT were loaded onto a 7.5%
SDS-PAGE, transferred to a nitrocellulose membrane, and immunoblotted
with an affinity-purified hTERT antibody (kindly provided by Dr L. Harrington). As controls, T7-hTERT (lane 1) and hTR
(lane 2) synthesized and added, respectively, in a RRL were
included. The 83- and 175-kDa molecular mass markers are indicated on
the right. GLU, glucose; GAL,
galactose.

View larger version (44K):
[in a new window]
Fig. 3.
Reconstitution of human telomerase activity
in S. cerevisiae by co-expression of hTERT and
hTR. A, yeast transformed with the following constructs
were grown and induced with galactose (except for lane 5):
pEGKT-hTERT and p413 vector (lane 1); pEGKT-hTERT and
p413/antisense hTR (
hTR) (lane 2); pEGKT-hTERT
clone 1 (C1) and p413-hTR (lane 3); pEGKT-hTERT clone 4 (C4)
and p413/hTR (lane 4); pEGKT-hTERT clone 4 (C4) and p413/hTR
grown in the presence of glucose (GLU) (lane 5);
pEGKT-hTERT D868N and p413/hTR (lane 6); pEGKT vector and
p413/hTR (lane 7). Yeast lysates were subjected to
immunoprecipitation using a goat anti-GST serum, and the
immunoprecipitates (IP) were analyzed for: A,
telomerase activity; B, expression of GST-hTERT by Western
blot (WB); and C, expression and association of
hTR with hTERT by RT-PCR using hTR-specific primers. For panels
A-C, lanes 1-7 correspond to the constructs
described above. In A, telomerase activity was analyzed by
the TRAP assay, and 50 ng of partially purified 293 cell extract was
used as a positive control (lane 8). IC
represents the internal PCR control; G-hTERT,
GST-hTERT. In B, a Western blot was performed using an
affinity-purified anti-hTERT antibody. IgG, the
immunoglobulins used during the immunoprecipitation. The position of
the protein markers are indicated on the right in kDa. In
C, RT-PCR was performed in the absence (
) or presence (+)
of in vitro synthesized hTR as controls reactions.
Lane M was loaded with a 100-bp ladder.

View larger version (76K):
[in a new window]
Fig. 4.
S. cerevisiae lysate does not stimulate
in vitro reconstitution of human telomerase RNP.
Rabbit reticulocyte lysate (RRL)-expressed GST-hTERT (no
hTR) and S. cerevisiae-expressed (no hTR) GST-hTERT
wild-type and D868N mutant were immunoprecipitated (IP)
using anti-GST serum. Immunoprecipitated proteins were washed
extensively (five times) and incubated with 200 ng of either human or
T. thermophila telomerase RNA in the presence or absence of
fresh yeast protein extract. After 45 min at 30 °C, reconstitution
reactions were diluted to 40 µl and assayed for telomerase activity
by TRAP analysis. IC, internal PCR control; SC, S. cerevisiae. As a positive control, 50 ng of partially purified 293 cell extract was used (lane 10).
| |
ACKNOWLEDGEMENT |
|---|
The hTERT cDNA was provided by Geron Corporation (Menlo Park, CA). We are grateful to L. Harrington (Ontario Cancer Institute-Amgen Institute) for the affinity-purified hTERT (TP2) anti-peptide serum. We thank P. Belhumeur (Université de Montréal) for the plasmids and yeast strain and M. Clément for technical advice on yeast genetics. We also thank G. Kukolj, A. Koromilas, and T. Moriarty for helpful discussions and critical reading of the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by Medical Research Council of Canada (MRCC) Grant MT-14026 (to C. A.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Recipient of a doctoral research award from the MRCC.
§ To whom correspondence should be addressed: Bloomfield Centre for Research in Aging, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, 3755 chemin Cote Ste. Catherine, Montréal, Québec H3T 1E2, Canada. Tel.: 514-340-8260; Fax: 514-340-8295; E-mail: mcfj@musica.mcgill.ca.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: RNP, ribonucleoprotein; hTERT, human telomerase reverse transcriptase; hTR, human telomerase RNA; GST, glutathione S-transferase; RRL, rabbit reticulocyte lysate; TRAP, telomeric repeat amplification protocol; RT, reverse transcription; PCR, polymerase chain reaction; bp, base pair(s); PAGE, polyacrylamide gel electrophoresis; TMG buffer, TRIS-HCl, pH 8.0, MgCl2, and glycerol.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Autexier, C., and Greider, C. W. (1996) Trends Biochem. Sci. 21, 387-391[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Reddel, R. R. (1998) BioEssays 20, 977-984[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | O'Reilly, M., Teichmann, S. A., and Rhodes, D. (1999) Curr. Opin. Struct. Biol. 9, 56-65[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Pardue, M.-L., and DeBaryshe, P. G. (1999) Chromosoma 108, 73-82[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Colgin, L. M., and Reddel, R. R. (1999) Curr. Opin. Genet. Dev. 9, 97-103[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Nugent, C. I.,
and Lundblad, V.
(1998)
Genes Dev.
12,
1073-1085 |
| 7. |
Nakamura, T. M.,
Morin, G. B.,
Chapman, K. B.,
Weinrich, S. L.,
Andrews, W. H.,
Lingner, J.,
Harley, C. B.,
and Cech, T. R.
(1997)
Science
277,
955-959 |
| 8. | Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Dickinson, S. C., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., Bacchetti, S., Haber, D. A., and Weinberg, R. A. (1997) Cell 90, 785-795[CrossRef][Medline] [Order article via Infotrieve] |
| 9. |
Harrington, L.,
Zhou, W.,
McPhail, T.,
Oulton, R.,
Yeung, D. S. K.,
Mar, V.,
Bass, M. B.,
and Robinson, M. O.
(1997)
Genes Dev.
11,
3109-3115 |
| 10. |
Kilian, A.,
Bowtell, D. D. L.,
Abud, H. E.,
Hime, G. R.,
Venter, D. J.,
Keese, P. K.,
Duncan, E. L.,
Reddel, R. R.,
and Jefferson, R. A.
(1997)
Hum. Mol. Genet.
6,
2011-2019 |
| 11. | Autexier, C., Pruzan, R., Funk, W. D., and Greider, C. W. (1996) EMBO J. 15, 5928-5935[Medline] [Order article via Infotrieve] |
| 12. | Weinrich, S. L., Pruzan, R., Ma, L., Ouellette, M., Tesmer, V. M., Holt, S. E., Bodnar, A. G., Lichtsteiner, S., Kim, N. W., Trager, J. B., Taylor, R. D., Carlos, R., Andrews, W. H., Wright, W. E., Shay, J. W., Harley, C. B., and Morin, G. B. (1997) Nat. Genet. 17, 498-502[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Beattie, T. L., Zhou, W., Robinson, M. O., and Harrington, L. (1998) Curr. Biol. 8, 177-180[CrossRef][Medline] [Order article via Infotrieve] |
| 14. |
Collins, K.,
and Gandhi, L.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
8485-8490 |
| 15. |
Harrington, L.,
McPhail, T.,
Mar, V.,
Zhou, W.,
Oulton, R.,
Bass, M. B.,
Arruda, I.,
and Robinson, M. O.
(1997)
Science
275,
973-977 |
| 16. |
Holt, S. E.,
Aisner, D. L.,
Baur, J.,
Tesmer, V. M.,
Dy, M.,
Ouellette, M.,
Trager, J. B.,
Morin, G. M.,
Toft, D. O.,
Shay, J. W.,
Wright, W. E.,
and White, M. A.
(1999)
Genes Dev.
13,
817-826 |
| 17. |
Licht, J. D.,
and Collins, K.
(1999)
Genes Dev.
13,
1116-1125 |
| 18. |
Kim, N. W.,
Piatyszek, M. A.,
Prowse, K. R.,
Harley, C. B.,
West, M. D.,
Ho, P. L. C.,
Coviello, G. M.,
Wright, W. E.,
Weinrich, S. L.,
and Shay, J. W.
(1994)
Science
266,
2011-2015 |
| 19. | Shay, J. W., and Bacchetti, S. (1997) Eur. J. Cancer 33, 787-791 |
| 20. | Dubois, N., Colina, A. R., Aumont, F., Belhumeur, P., and de Repentigny, L. (1998) Microbiology 144, 2299-3110[Abstract] |
| 21. | Lennon, G. G., Auffray, C., Polymeropoulos, M., and Soares, M. B. (1996) Genomics 33, 151-152[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Mitchell, D. A., Marshall, T. K., and Deschenes, R. J. (1993) Yeast 9, 715-723[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Ausubel, F. M., Brent, R., Kingston, R., Moore, D., Seidman, J. G., Smith, J. A., and Struhl, K. (1998) Current Protocols in Molecular Biology , Wiley and Sons, Inc., New York |
| 24. |
Feng, J.,
Funk, W. D.,
Wang, S.-S.,
Weinrich, S. L.,
Avilion, A. A.,
Chiu, C.-P.,
Adams, R. R.,
Chang, E.,
Allsopp, R. C., Yu, J.,
Le, S.,
West, M. D.,
Harley, C. B.,
Andrews, W. H.,
Greider, C. W.,
and Villeponteau, B.
(1995)
Science
269,
1236-1241 |
| 25. |
Mumberg, D.,
Muller, R.,
and Funk, M.
(1994)
Nucleic Acids Res.
22,
5767-5768 |
| 26. |
Cohn, M.,
and Blackburn, E. H.
(1995)
Science
269,
396-400 |
| 27. |
Autexier, C.,
and Greider, C. W.
(1994)
Genes Dev.
8,
563-575 |
| 28. |
Kim, N. W.,
and Wu, F.
(1997)
Nucleic Acids Res.
25,
2595-2597 |
| 29. |
Lingner, J.,
Hughes, T. R.,
Shevchenko, A.,
Mann, M.,
Lundblad, V.,
and Cech, T. R.
(1997)
Science
276,
561-567 |
| 30. |
Counter, C. M.,
Meyerson, M.,
Eaton, E. N.,
and Weinberg, R. A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
9202-9207 |
| 31. |
Henning, K. A.,
Moskowitz, N.,
Ashlock, M. A.,
and Liu, P. P.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
5667-5671 |
This article has been cited by other articles:
![]() |
B. S. Emerald, Y. Chen, T. Zhu, Z. Zhu, K.-O. Lee, P. D. Gluckman, and P. E. Lobie {alpha}CP1 Mediates Stabilization of hTERT mRNA by Autocrine Human Growth Hormone J. Biol. Chem., January 5, 2007; 282(1): 680 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Cerone, J. A. Londono-Vallejo, and C. Autexier Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells. Mol. Cancer Ther., July 1, 2006; 5(7): 1669 - 1675. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Marie-Egyptienne, M. A. Cerone, J. A. Londono-Vallejo, and C. Autexier A human-Tetrahymena pseudoknot chimeric telomerase RNA reconstitutes a nonprocessive enzyme in vitro that is defective in telomere elongation Nucleic Acids Res., September 28, 2005; 33(17): 5446 - 5457. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. MORIARTY, D. T. MARIE-EGYPTIENNE, and C. AUTEXIER Regulation of 5' template usage and incorporation of noncognate nucleotides by human telomerase RNA, September 1, 2005; 11(9): 1448 - 1460. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Jacobs, E. R. Podell, D. S. Wuttke, and T. R. Cech Soluble domains of telomerase reverse transcriptase identified by high-throughput screening Protein Sci., August 1, 2005; 14(8): 2051 - 2058. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Moriarty, R. J. Ward, M. A.S. Taboski, and C. Autexier An Anchor Site-Type Defect in Human Telomerase That Disrupts Telomere Length Maintenance and Cellular Immortalization Mol. Biol. Cell, July 1, 2005; 16(7): 3152 - 3161. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, H. Feng, X.-Q. Huang, H. Xiang, Y.-W. Mao, J.-P. Liu, Q. Yan, W.-B. Liu, Y. Liu, M. Deng, et al. Human Telomerase Reverse Transcriptase Immortalizes Bovine Lens Epithelial Cells and Suppresses Differentiation through Regulation of the ERK Signaling Pathway J. Biol. Chem., June 17, 2005; 280(24): 22776 - 22787. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Hartig and E. T. Kool Small circular DNAs for synthesis of the human telomere repeat: varied sizes, structures and telomere-encoding activities Nucleic Acids Res., November 1, 2004; 32(19): e152 - e152. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Oulton and L. Harrington A Human Telomerase-associated Nuclease Mol. Biol. Cell, July 1, 2004; 15(7): 3244 - 3256. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Moriarty, D. T. Marie-Egyptienne, and C. Autexier Functional Organization of Repeat Addition Processivity and DNA Synthesis Determinants in the Human Telomerase Multimer Mol. Cell. Biol., May 1, 2004; 24(9): 3720 - 3733. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Huard and C. Autexier Human telomerase catalyzes nucleolytic primer cleavage Nucleic Acids Res., April 19, 2004; 32(7): 2171 - 2180. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bah, F. Bachand, E. Clair, C. Autexier, and R. J. Wellinger Humanized telomeres and an attempt to express a functional human telomerase in yeast Nucleic Acids Res., March 26, 2004; 32(6): 1917 - 1927. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Huard, T. J. Moriarty, and C. Autexier The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity Nucleic Acids Res., July 15, 2003; 31(14): 4059 - 4070. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Cong, W. E. Wright, and J. W. Shay Human Telomerase and Its Regulation Microbiol. Mol. Biol. Rev., September 1, 2002; 66(3): 407 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. R. Banik, C. Guo, A. C. Smith, S. S. Margolis, D. A. Richardson, C. A. Tirado, and C. M. Counter C-Terminal Regions of the Human Telomerase Catalytic Subunit Essential for In Vivo Enzyme Activity Mol. Cell. Biol., September 1, 2002; 22(17): 6234 - 6246. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bachand, F.-M. Boisvert, J. Cote, S. Richard, and C. Autexier The Product of the Survival of Motor Neuron (SMN) Gene is a Human Telomerase-associated Protein Mol. Biol. Cell, September 1, 2002; 13(9): 3192 - 3202. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Etheridge, S. S. R. Banik, B. N. Armbruster, Y. Zhu, R. M. Terns, M. P. Terns, and C. M. Counter The Nucleolar Localization Domain of the Catalytic Subunit of Human Telomerase J. Biol. Chem., June 28, 2002; 277(27): 24764 - 24770. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pascolo, C. Wenz, J. Lingner, N. Hauel, H. Priepke, I. Kauffmann, P. Garin-Chesa, W. J. Rettig, K. Damm, and A. Schnapp Mechanism of Human Telomerase Inhibition by BIBR1532, a Synthetic, Non-nucleosidic Drug Candidate J. Biol. Chem., May 3, 2002; 277(18): 15566 - 15572. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Moriarty, S. Huard, S. Dupuis, and C. Autexier Functional Multimerization of Human Telomerase Requires an RNA Interaction Domain in the N Terminus of the Catalytic Subunit Mol. Cell. Biol., February 15, 2002; 22(4): 1253 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Armbruster, S. S. R. Banik, C. Guo, A. C. Smith, and C. M. Counter N-Terminal Domains of the Human Telomerase Catalytic Subunit Required for Enzyme Activity in Vivo Mol. Cell. Biol., November 15, 2001; 21(22): 7775 - 7786. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. X. Mason, C. Autexier, and C. W. Greider Tetrahymena proteins p80 and p95 are not core telomerase components PNAS, October 5, 2001; (2001) 221456398. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Beattie, W. Zhou, M. O. Robinson, and L. Harrington Functional Multimerization of the Human Telomerase Reverse Transcriptase Mol. Cell. Biol., September 15, 2001; 21(18): 6151 - 6160. [Abstract] [Full Text] [PDF] |
||||